IRIS
LENCI, ILARIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 6.147
EU - Europa 478
AS - Asia 451
Continente sconosciuto - Info sul continente non disponibili 5
SA - Sud America 4
AF - Africa 2
OC - Oceania 1
Totale 7.088
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 6.143
SG - Singapore 239
IE - Irlanda 154
IT - Italia 110
CN - Cina 90
KR - Corea 75
GB - Regno Unito 51
DE - Germania 45
UA - Ucraina 22
RU - Federazione Russa 21
SE - Svezia 16
FI - Finlandia 15
FR - Francia 14
BE - Belgio 12
CZ - Repubblica Ceca 11
HK - Hong Kong 10
IN - India 9
PK - Pakistan 6
EU - Europa 4
QA - Qatar 4
TM - Turkmenistan 4
VN - Vietnam 4
BR - Brasile 3
CA - Canada 3
IR - Iran 3
EG - Egitto 2
PL - Polonia 2
TW - Taiwan 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AT - Austria 1
AU - Australia 1
CH - Svizzera 1
CL - Cile 1
ES - Italia 1
GR - Grecia 1
IL - Israele 1
IQ - Iraq 1
JP - Giappone 1
KW - Kuwait 1
MY - Malesia 1
NO - Norvegia 1
SV - El Salvador 1
Totale 7.088
Salva come PNG Salva come JPEG
Città #
Wilmington 1.912
Houston 1.569
Woodbridge 520
Fairfield 369
Chandler 321
Singapore 207
Ashburn 189
Dublin 134
Seattle 116
Cambridge 115
Medford 105
New York 99
Ann Arbor 91
Lawrence 48
Rome 47
Santa Clara 47
Beijing 40
San Diego 30
Menlo Park 26
Seoul 22
Dearborn 21
Palo Alto 18
Creede 14
Engelhard 14
Moscow 14
London 13
Brussels 12
Jacksonville 11
Munich 11
Washington 11
Helsinki 10
Redwood City 10
Boardman 9
Colorado Springs 9
Hefei 8
Brno 7
Hangzhou 7
Los Angeles 7
Council Bluffs 6
Hong Kong 6
Hounslow 6
Miami 6
Nanjing 6
Shanghai 6
Lahore 5
Milan 5
Nuremberg 5
St. George 5
Cagliari 4
Cassino 4
Doha 4
Dong Ket 4
Islington 4
Kilburn 4
La Veta 4
Norwalk 4
Bloomfield 3
Guangzhou 3
Las Vegas 3
Mountain View 3
Nanchang 3
Olomouc 3
Toronto 3
Zhengzhou 3
Central 2
Chateaugiron 2
Chiswick 2
Clearwater 2
Esslingen am Neckar 2
Falls Church 2
Fremont 2
Guidonia Montecelio 2
Hanover 2
Jinan 2
Lappeenranta 2
Saint Petersburg 2
San Mateo 2
Shenyang 2
Southwark 2
São Paulo 2
Taipei 2
Tappahannock 2
Tianjin 2
Turin 2
Xuzhou 2
Adliswil 1
Ariano Irpino 1
Athens 1
Bangalore 1
Basra 1
Changchun 1
Chaoyang 1
Frankfurt am Main 1
Genzano di Roma 1
Georgetown 1
Gunzenhausen 1
Haifa 1
Hebei 1
Hyderabad 1
Indiana 1
Totale 6.382
Salva come PNG Salva come JPEG
Nome #
HCV-RNA quantification in liver bioptic samples and extrahepatic compartments, using the abbott RealTime HCV assay 443
Evidence of Spontaneous Post-transplant HCV Eradication in Two Failed DAA Treatments Awaiting Liver Transplantation 366
Improvement of ALT decay kinetics by all-oral HCV treatment: Role of NS5A inhibitors and differences with IFN-based regimens 363
Ab initio Everolimus-based Versus Standard Calcineurin Inhibitor Immunosuppression Regimen in Liver Transplant Recipients 301
Sofosbuvir plus daclatasvir with or without ribavirin is safe and effective for post-transplant hepatitis C recurrence and severe fibrosis and cirrhosis: A prospective study 298
HDV can constrain HBV genetic evolution in hbsag: Implications for the identification of innovative pharmacological targets 283
Clinical Operational Tolerance and Immunosuppression Minimization in Kidney Transplantation: Where Do We Stand? 279
An unusual duodenal polyp causing anemia in a liver-transplanted patient 274
Pitfalls in the reporting of upper endoscopy features in cirrhotic patients 256
Trans-splenic Embolization Plus Partial Splenic Embolization for Management of Variceal Bleeding Due to Left-Sided Portal Hypertension 253
Direct-acting antivirals and hepatocellular carcinoma in chronic hepatitis C: A few lights and many shadows 245
Impact of new DAA therapy on real clinical practice: A multicenter region-wide cohort study 233
Recurrence of hepatocellular carcinoma after direct acting antiviral treatment for hepatitis C virus infection: Literature review and risk analysis 229
Effect of direct-acting antivirals on future occurrence of hepatocellular carcinoma in compensated cirrhotic patients 222
Dual role of bile acids on the biliary epithelium: Friend or foe? 188
HCV resistance compartmentalization within tumoral and non-tumoral liver in transplanted patients with hepatocellular carcinoma 178
Platelets and hepatocellular cancer: Bridging the bench to the clinics 160
Liver transplantation for hepatocellular carcinoma: Where do we stand? 159
Prevention of hepatitis C recurrence by bridging sofosbuvir/ribavirin from pre- to post-liver transplant: A real-life strategy 153
Evaluation of liver fibrosis in cirrhotic patients: comparison between elastosonography and fibroscan 153
Domino liver transplantation: Where are we now? 148
Tips for TIPS: A combined percutaneous and transjugular approach for intrahepatic portosystemic shunt placement after liver transplant 144
Vascular anomalies of the celiac trunk and implications in treatment of HCC with TACE. Description of a case and review of the literature 141
null 131
Daclatasvir, sofosbuvir with or without ribavirin for 24 weeks in hepatitis C genotype 3 cirrhosis: A real-life study 116
Transarterial chemoembolization for hepatocellular carcinoma in Fontan surgery patient 97
Cholangiocarcinoma: Bridging the translational gap from preclinical to clinical development and implications for future therapy 90
Pro-inflammatory signalling and gut-liver axis in non-alcoholic and alcoholic steatohepatitis: Differences and similarities along the path 89
Serum Levels of Granulocyte-Macrophage-colony-stimulating Factor and Stem-cell Factor During Liver Regeneration after Partial Hepatectomy in Humans 78
Natremia and liver transplantation: The right amount of salt for a good recipe 65
Successful ongoing retreatment with glecaprevir/pibrentasvir + sofosbuvir + ribavirin in a patient with HCV genotype 3 who failed glecaprevir/pibrentasvir with both NS3 and NS5A resistance 65
Hepatitis B virus recurrence after liver transplantation: An old tale or a clear and present danger? 63
Functional Role of the Secretin/Secretin Receptor Signaling During Cholestatic Liver Injury 57
Genetic Determinants in a Critical Domain of NS5A Correlate with Hepatocellular Carcinoma in Cirrhotic Patients Infected with HCV Genotype 1b 56
Current strategies to minimize ischemia-reperfusion injury in liver transplantation: a systematic review 48
Cyclic AMP Signaling in Biliary Proliferation: A Possible Target for Cholangiocarcinoma Treatment? 43
Resistance analysis and treatment outcomes in hepatitis C virus genotype 3-infected patients within the Italian network VIRONET-C 42
Gastrointestinal endoscopy in cirrhotic patient: Issues on the table 41
Molecular Mechanisms Linking Risk Factors to Cholangiocarcinoma Development 40
COVID-19 in normal, diseased and transplanted liver 39
Correction to: Immunosuppressive regimens for adult liver transplant recipients in real-life practice: consensus recommendations from an Italian Working Group (Hepatology International, (2020), 14, 6, (930-943), 10.1007/s12072-020-10091-5) 37
Moving forward in the treatment of cholangiocarcinoma 35
Liver transplantation performed in a SARS-CoV-2 positive hospitalized recipient using a SARS-CoV-2 infected donor 34
Chronic rejection after liver transplantation: Opening the Pandora's box 34
Electronic Outpatient Referral System for Liver Transplant Improves Appropriateness and Allows First Visit Triage 34
Role of Cone-Beam CT in the Intraprocedural Evaluation of Chemoembolization of Hepatocellular Carcinoma 30
New strategies on management of hepatitis b virus after liver transplantation: complete and sustained weaning of hbv prophylaxis in a selected cohort of patients transplanted due to hbv-related cirrhosis 30
The acquisition of positively charged amino acids in HBsAg C-terminus correlates with HBV-induced liver cancer in vivo, impairs HBsAg secretion and affects its structural stability in vitro 29
Towards tolerance in liver transplantation 27
Successful clinical and virological outcomes of liver transplantation for HDV/HBV-related disease after long-term discontinuation of hepatitis B immunoglobulins 26
Overview of prognostic systems for hepatocellular carcinoma and ITA.LI.CA external validation of MESH and CNLC classifications 26
The role of antiplatelet therapies on incidence and mortality of hepatocellular carcinoma 26
Repeated TACE in HCC after Fontan surgery and situs viscerum inversus: A case report 25
Sarco-Model: A score to predict the dropout risk in the perspective of organ allocation in patients awaiting liver transplantation 24
The acquisition of positively charged amino acids in HBsAg C- terminus impairs HBsAg secretion, affects its structural stability and is associated with HBV-induced liver cancer 23
null 22
The Italian data on SARS-CoV-2 infection in transplanted patients support an organ specific immune response in liver recipients 21
Superiority of the new sex-adjusted models to remove the female disadvantage restoring equity in liver transplant allocation 21
Secondary bile acids and the biliary epithelia: The good and the bad 21
Use of Intravascular Ultrasound to Improve Diagnosis and Treatment of Transjugular Intrahepatic Portosystemic Shunt Dysfunction in Patients in the Long-term Follow-up 21
THE ENRICHMENT OF POSITIVELY CHARGED AMINO ACIDS IN HBsAg C-TERMINUS IMPAIRS HBsAg SECRETION, AFFECTS ITS STRUCTURAL STABILITY AND IS CORRELATED WITH HBV-INDUCED LIVER CANCER. 21
Prevalence of HDV infection in Central Italy has remained stable across the last two decades with dominance of sub-genotypes 1 and characterized by elevated viral replication 19
HDV epidemic in Central Italy is stable over the last two decades and is characterized by the circulation of multiple HDV subgenotypes 1 inducing different inflammatory stimuli 18
Higher levels of three HBsAg forms (Large, Middle and Small HBsAg) are associated with HDV replication and with the degree of disease and liver damage. 17
HDV replicative activity parallels the production of the three HBsAg forms (Large, Middle and Small HBsAg) and its pathogenetic impact is exacerbated by concomitant HBV replication 15
Stable temporal trend of HDV seroprevalence in central Italy across the last two decades with the circulation of HDV sub-genotypes 1 inducing different inflammatory stimuli 15
Saline Contrast Echocardiography in Patients With Hepatopulmonary Syndrome Awaiting Liver Transplantation 13
Benign disease and unexpected histologocal findings after pancreaticoduodenectomy: The role of endoscopic ultrasound fine needle aspiration 12
Renal Function, Adherence and Quality of Life Improvement After Conversion From Immediate to Prolonged-Release Tacrolimus in Liver Transplantation: Prospective Ten-Year Follow-Up Study 10
Sequence of events leading to primary biliary cholangitis 10
Reduction in bile leaks following adult split liver transplant using a fibrin-collagen sponge: A pilot study 10
HDV INFECTION IS STABLE IN CENTRAL ITALY ACROSS THE LAST TWO DECADES AND IS CHARACTERIZED BY THE CIRCULATION OF MULTIPLE HDV SUB-GENOTYPES 1 WITH A DIFFERENT PRO-INFLAMMATORY POTENTIAL 9
PATHWAYS UNDERLYING HDV PERSISTENCE ACT INDEPENDENTLY FROM THE EXTENT OF HBV RESEVOIR AND ARE SUSTAINED BY AN ABUNDANT PRODUCTION OF HBSAG DERIVED FROM INTEGRATED HBV-DNA P 214 9
The intrahepatic activity of Hepatitis Delta virus is sustained by an abundant production of HBs transcripts, mainly derived from integrated HBV-DNA, and is not strictly related to the extent of HBV reservoir 9
De novo malignancies after liver transplantation: The effect of immunosuppression-personal data and review of literature 4
The Effects of Sustained Immunosuppression Withdrawal After Liver Transplantation on Metabolic Syndrome 2
Totale 7.368
Salva come PNG Salva come JPEG
Categoria #
all - tutte 25.056
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 25.056
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.739 0 0 103 150 122 154 189 156 230 233 193 209
2020/20211.884 194 198 189 196 205 273 252 212 27 81 30 27
2021/2022606 28 62 18 27 9 72 46 24 71 60 38 151
2022/2023805 75 79 46 88 80 156 72 72 73 11 32 21
2023/2024490 60 16 43 13 65 138 12 15 14 54 4 56
2024/2025415 57 357 1 0 0 0 0 0 0 0 0 0
Totale 7.368